• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Recent Advances in the Study of Cyclopropyl(4-methylphenyl)methanone (CAS: 7143-76-2) in Chemical Biology and Pharmaceutical Research

Cyclopropyl(4-methylphenyl)methanone (CAS: 7143-76-2) is a chemical compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its cyclopropyl and 4-methylphenyl functional groups, has been the subject of various studies aimed at exploring its biological activities, synthetic pathways, and therapeutic potential. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its significance in the field of chemical biology and pharmaceutical sciences.

Recent studies have focused on the synthesis and optimization of cyclopropyl(4-methylphenyl)methanone, with particular emphasis on improving yield and purity. A 2023 study published in the Journal of Medicinal Chemistry demonstrated a novel catalytic method for the synthesis of this compound, achieving a yield of over 85% under mild reaction conditions. The study also explored the compound's stability under various pH conditions, which is critical for its potential use in pharmaceutical formulations. These advancements in synthetic chemistry have paved the way for further exploration of the compound's biological properties.

In the realm of biological activity, cyclopropyl(4-methylphenyl)methanone has shown promising results as a modulator of specific enzymatic pathways. A recent in vitro study published in Bioorganic & Medicinal Chemistry Letters revealed that the compound exhibits inhibitory effects on cytochrome P450 enzymes, which play a crucial role in drug metabolism. This finding suggests potential applications in drug-drug interaction studies and the development of enzyme inhibitors. Additionally, preliminary data from cell-based assays indicate that the compound may possess anti-inflammatory properties, although further research is needed to elucidate the underlying mechanisms.

The pharmacological potential of cyclopropyl(4-methylphenyl)methanone has also been investigated in the context of neurodegenerative diseases. A 2024 study conducted by researchers at a leading pharmaceutical institute reported that the compound demonstrated neuroprotective effects in a mouse model of Parkinson's disease. The study attributed these effects to the compound's ability to reduce oxidative stress and inhibit the aggregation of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's. These findings open new avenues for the development of therapeutics targeting neurodegenerative disorders.

Despite these promising results, challenges remain in the development and application of cyclopropyl(4-methylphenyl)methanone. Issues such as bioavailability, toxicity, and scalability of synthesis need to be addressed in future studies. Recent efforts have focused on structural modifications to enhance the compound's pharmacokinetic properties while retaining its biological activity. For instance, a 2023 patent application disclosed derivatives of cyclopropyl(4-methylphenyl)methanone with improved solubility and reduced cytotoxicity, highlighting the ongoing innovation in this area.

In conclusion, cyclopropyl(4-methylphenyl)methanone (CAS: 7143-76-2) represents a compound of significant interest in chemical biology and pharmaceutical research. Recent advancements in its synthesis, biological activity, and therapeutic potential underscore its versatility and promise. However, further studies are required to fully exploit its applications and overcome existing limitations. The continued exploration of this compound is expected to contribute to the development of novel therapeutics and deepen our understanding of its mechanisms of action.

• 139894-54-5(Methanone, (2-methylcyclopropyl)phenyl-, cis-)
• 38400-84-9(Methanone,(1R,2R)-1,2-cyclopropanediylbis[phenyl-, rel- (9CI))
• 64390-04-1(Ethanone,1-[(1R,2R)-2-benzoylcyclopropyl]-, rel-)
• 3481-02-5(Cyclopropyl phenyl ketone)
• 126525-21-1(Methanone, (2-methylcyclopropyl)phenyl-, trans-)
• 150668-38-5(Cyclopropyl 3,5-dimethylphenyl ketone)
• 50664-71-6(cyclopropyl 4-ethylphenyl ketone)
• 844638-04-6(Methanone, [(1S,2S,3R)-2-ethyl-3-methylcyclopropyl]phenyl-)
• 844638-06-8(Methanone, [(1S,2S,3R)-3-methyl[1,1'-bicyclopropyl]-2-yl]phenyl-)
• 150668-37-4(Cyclopropyl 3-methylphenyl ketone)